Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBI-002 in Adolescents and Adults With Sickle Cell Disease
NCT06144749Phase 2Completed
- Sponsor
- Hillhurst Biopharmaceuticals
- Start
- Feb 2025
- Primary completion
- Jun 2026
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Carbon monoxide in sickle cell anemia (SCA), sponsored by Hillhurst Biopharmaceuticals. Started Feb 2025; status: completed.
02
Drugs
Carbon monoxide
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT06144749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06144749.